|
Indian
Pharma Congress to deliberate on drug discovery
Pharma experts to chart a roadmap for boosting Drug Discovery
Research in the 57th IPC, Falaknaaz Syed, gives an overview
of the forthcoming event.
India
as a hub for biogenerics
A biogeneric is defined as the generic alternative of a biopharmaceutical
or biologic, which is a copy of the original product.
A
pharmacist's journey
Pharmacy is the art and science of preparing and dispensing
medication and provision of drug-related information to the
public.
The
Patent Law harmony
Keeping in view of the fact that there are highly divergent
interests and priorities of developed and developing countries,
manoeuvring of MNCs for harmonisation of patent laws has been
a point of contention for a long time.
Opportunities
and challenges for clinical research in India
Clinical Research may be defined as organised research conducted
on human beings, intended to provide adequate information
on drug use as a therapeutic agent on its safety, efficacy
and adverse effects.
TRIPS
& Indian Healthcare: The Road Ahead
The 57th Indian Pharmaceutical Cong-ress at Hyderabad in December
2005 takes place in the backdrop of a completely changed patent
regime in India.
'Indian
pharma firms ready for African safari'
The withdrawal of the patent suit filed by 39 global pharma
companies against the South African government, which allowed
the sale of cheaper branded generic drugs, opens up a huge
window of opportunity for selling generic drugs to the South
African market, according to an Assocham study.
Biogenerics
all set to revolutionise Indian pharma scenario
Based on biologically active substances, biogenerics are generic
versions of patent protected biologicals or protein drugs.
Healthcare
industry eyes 'alternatives'
Fundamental changes in the dynamics of the healthcare industry
are fuelling the growth of a scientifically driven nutrition
industry.
CRO
Industry: Global Trends and Local Lessons
India's interest in global clinical trials has led to rise
of a new industry - Clinical Research Orgnanisations (CRO).
Several local investment groups and Indian pharma companies
have set up CROs to cash on the opportunity.
Ethics
and Pharmaceutical Marketing: The Pfizer Way
The pharmaceutical industry faces challenges with respect
to ethical marketing and promotional practices.
Data
Protection - A Building Block for Pharmaceutical R&D
To improve the global health situation and access to healthcare,
mere discovery of a new pharmaceutical entity or a vaccine
is not sufficient.
|
